FOIAengine: FDA Weight Loss Drug FOIA Requests Grow Leading makers of GLP-1 (Glucagon-Like Peptide-1) weight loss drugs like Ozempic and Zepbound are facing off against domestic compounding pharmacies that import foreign ingredients and make cheaper, non-approved...
FOIAengine: How Obscure MMTLP Became a Cause Célèbre At the Securities and Exchange Commission, the inbox has been filling up with hundreds of near-identical Freedom of Information Act requests about a little-known company called Meta Materials, Inc., whose stock...
FOIAengine: Over 100 FOIA Requests to Federal Agencies As the Trump Administration moves rapidly to install artificial intelligence throughout the federal government, a growing number of journalists, non-profits, lawyers, and executives are filing Freedom of...
FOIAengine Highlights the Latest Media and Watchdog Requests The latest batch of Freedom of Information Act requests to the Treasury Department and Federal Reserve Board offers a window into what journalists, watchdog groups, and political operatives think is worth...
FOIAengine: Wall Street Journal Seeking SEC Emails and Texts Involving the Trump-Affiliated Venture Capital Firm The Wall Street Journal is pressing the Securities and Exchange Commission for records involving Trump-affiliated 1789 Capital – a timely request after a...
FOIAengine: Maker of Elevidys Targeted by 91 FOIA Requests in 19 Months As biotech firm Sarepta Therapeutics (NASD: SRPT) battles patient deaths, regulatory action, and a cratering stock price, its dealings with the Food and Drug Administration are being monitored...
